Curaleaf Announces January Investor Community Conference and Event Participation

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company") a leading international provider of consumer products in cannabis, today announced that members of Curaleaf's executive management team will be participating in the following investor community conferences and events during January 2022 .

  • ICR Conference 2022
    January 10 , 2022
    Joseph Lusardi , Executive Vice Chairman of Curaleaf, will be participating in a fireside chat with Vivien Azer , Cowen Equity Analyst, from 11:30am – 12:00pm ET .
    Curaleaf management will also be hosting investor meetings.

  • 24 th Annual Needham Virtual Growth Conference
    January 12, 2022
    Boris Jordan , Executive Chairman of Curaleaf, will be participating in a fireside chat with Matt McGinley , Needham Equity Analyst, from 11:30am – 12:10pm ET .
    Curaleaf management will also be hosting investor meetings.

  • ATB's 10 th Annual Institutional Conference
    January 13, 2022
    Joe Bayern , CEO of Curaleaf, will be participating in a panel titled, "East Coast: The Heat Is
    On This Winter" hosted by Kenric Tyghe , ATB Equity Analyst, from 10:00am – 10:50am ET .
    Curaleaf management will also be hosting investor meetings.

For more information regarding upcoming Curaleaf financial community conference and event participation as well as details to access the webcasts please visit Curaleaf's IR website at https://ir.curaleaf.com/events .

About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States , Curaleaf currently operates in 23 states with 117 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com .

Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR
Investor Toolkit: https://ir.curaleaf.com/investor-toolkit
Investor Relations Website: https://ir.curaleaf.com/

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Carlos Madrazo , SVP, Investor Relations and Capital Markets
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady , VP Corporate Communications
media@curaleaf.com

Cision View original content: https://www.prnewswire.com/news-releases/curaleaf-announces-january-investor-community-conference-and-event-participation-301454048.html

SOURCE Curaleaf Holdings, Inc.

Cision View original content: https://www.newswire.ca/en/releases/archive/January2022/04/c1378.html

News Provided by Canada Newswire via QuoteMedia

CURA:CNX,CURLF
The Conversation (0)
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News